Leinco Technologies, Inc.'s Anti-Human IL-2R alpha (CD25) (Basiliximab) - 100 mg monoclonal antibody. The Anti-Human IL-2R alpha (CD25) (Basiliximab) - 100 mg Antibody was generated using IL2RA as the antigen. It reacts with Homo Sapiens, Human, and Non-Human Primate. This antibody has been shown to work in applications such as: Blotting, Mass Cytometry, Flow Cytometry, Immunofluorescence, Immunohistochemistry, and Western Blot.